Insulet
PODD
#1851
Rank
NZ$19.48 B
Marketcap
NZ$281.34
Share price
-0.20%
Change (1 day)
-42.27%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2026 (TTM): NZ$5.80

According to Insulet's latest financial reports the company's current EPS (TTM) is NZ$5.72. In 2024 the company made an earnings per share (EPS) of NZ$10.17 an increase over its 2023 EPS that were of NZ$5.02.

EPS history for Insulet from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$5.80
2024NZ$10.17102.71%
2023NZ$5.024114.29%
2022NZ$0.12-69.57%
2021NZ$0.39109.09%
2020NZ$0.19-38.89%
2019NZ$0.31200%
2018NZ$0.10-113.04%
2017NZ-$0.78-9.8%
2016NZ-$0.87-60.47%
2015NZ-$2.1938.71%
2014NZ-$1.5812.05%
2013NZ-$1.41-23.15%
2012NZ-$1.84-12.2%
2011NZ-$2.09

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$14.86 159.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.14 7.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$6.36 11.31%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$48.03 740.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
NZ-$2.38-141.67%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
NZ$3.18-44.35%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
NZ$4.08-28.57%๐Ÿ‡บ๐Ÿ‡ธ USA